Meet the New SIGN CEO: DR. SARIAH KHORMAEE

Dr. Sariah Khormaee is an orthopaedic surgeon dedicated to advancing equality in musculoskeletal care. Before joining SIGN, she was an attending surgeon and researcher at the Hospital for Special Surgery (HSS) and an Assistant Professor at Weill Cornell Medical College. At HSS, she led an orthopaedic surgery practice focused on patients with spine conditions and ran a research lab that received multiple awards, including from the Kellen Family Foundation, AO Spine North America, and the Kevin Zoltan Merzei Foundation.

A native of Washington state, Dr. Khormaee graduated Summa Cum Laude from the University of Washington as President’s Medalist/Valedictorian. She then completed her MD at Harvard Medical School-MIT Health Sciences Technology with Honors. She earned her PhD from Cambridge University, United Kingdom, in Chemical Engineering and Biotechnology, receiving the Danckwerts-Pergamon Prize for best PhD. Completing her orthopaedic residency at Hospital for Special Surgery, Dr. Khormaee received multiple awards including the Distinguished Housestaff Award by HSS faculty for best graduating resident. She then finished spine fellowship at Stanford University Medical Center.

Dr. Khormaee’s work integrates bioengineering and orthopaedic care with a focus on global accessibility. She has collaborated with SIGN and other global health nonprofits, founded a research education organization, and travelled to orthopaedic hospitals, including multiple SIGN sites, in Ghana, Myanmar, and Vietnam. In her role as CEO of SIGN, she will continue to drive innovation and access to equality of fracture care worldwide.